Mineral density test

Central bone mineral density testing to evaluate the need for preventive or therapeutic bisphosphonate therapy ... 

Consider a bone mineral density test in patients with long-term hypogonadism. Additional Clinical Sequelae... 

Women older than 65 years of age or yonnger with risk factors for osteoporosis shonld have their bone mineral density measured. Although bone densitometry has been shown to predict fractures, at present there are no guidelines for follow-up bone mineral density testing. However, in women with significant bone loss, repeat testing should be performed as clinically indicated. 

Bone mineral density should be measured in women older than 65 years and in women younger than 65 years with risk factors for osteoporosis. Repeat testing should be done as clinically indicated. 

When fluoride dose has been tested in a controlled clinical trial, no adverse effects on bone mineral density have been detected. As expected from this finding, there have been no reports of increased susceptibility to bone fracture in these studies either. 

A bone mineral density (BMD) test measures the density of minerals (such as calcium) using X-ray, computed tomography (CT) or ultrasound. Dual-energy X-ray absorptiometry (DEXA) is the most accurate way to measure BMD. DEXA can measure as little as 2% of bone loss per year it is fast, uses low doses of radiation, but is more expensive than ultrasound. 

Ishikawa cell stimulation were then tested in ovariectomized rats for the ability to protect against loss of bone mineral density. It was found that GW5638 had antagonist properties on the uterus and agonist activities on bone and the cardiovascular system [59]. In further experiments it was shown that the biological properties of GW5638 derive from triggering a structural conformation of ER different from the conformations imposed by other SERMs [60]. Recently, several novel SERMs (e.g. bazedoxifene, lasofoxifene) have been identified with a combination of cellular screens, primarily uterine- and breast cell-based assays [61-63] (Scheme 1.4). 

Figure 14.4 Wood-plastic composite Nexwood (42% HDPE, 46% wood fiber, 12% minerals, density 1.17 g/cm3), hollow deck board, before and after 14 min of a fire test (by permission from the University of California Forest Products Laboratory).

In Women Loss of androgen secretion in women results in a decrease in sexual hair, but not for many years. Some experts have proposed that the loss of androgens, especially the severe loss of both ovarian and adrenal androgens that occurs in panhypopituitarism, is associated with decreased libido, energy, muscle mass and strength, and bone mineral density. Testosterone preparations that yield physiological serum testosterone concentrations in women currently are being developed and tested in clinical trials. 

Items 4-6 A 58-year-old postmenopausal woman was sent for dual-energy x-ray absorptiometry to evaluate the bone mineral density of her lumbar spine, femoral neck, and total hip. The test results revealed significantly low bone mineral density in all sites. 

Fig. 4. Effect of casein and soy protein with corn oil or fish oil on bone mineral density (BMD) in distal left femur of sham-operated and ovariectomized (OVX) Balb/C mice. Mice were fed an AIN-76 semipurified diet containing either 20% casein or 20% soy protein with dietary lipids supplied as either 10% corn oil or 10% fish oil. Means of bars not labeled with the same letter are significantly different at P< 0.05 by the New-man-KeuI test.

The density of charge is nearly constant over the whole range of pH if clay minerals are tested (Fig. 3). The negative charges increase in the order 1,2-dihydroxy-benzene, 4-methylbenzoic acid, benzoic acid, 2-hydroxy-benzoic acid. The change of the charge density strongly... 

FT-IR analysis to date has aided in understanding bone composition and quality in health [7, 157-161] as well as changes due to either tissue age [7, 157, 158, 161], subject aging [162, 163], disease [3, 30, 37-39, 43, 164-175-180], or in response to therapies due to disease [170, 173, 181-193]. We emphasize that even in cases that the widely clinically used bone strength surrogate of bone mineral density failed to correlate with fracture incidence or bone strength determined by biomechanical tests, FT-IR derived parameters such as mineral maturity/crystallinity and especially collagen cross-links have consistently revealed correlations [30,164,171,175,193]. 

Epidemiologic studies have consistently documented that increased potassium intake is associated with greater bone mineral density. In trials, supplemental potassium bicarbonate reduced bone turnover as manifest by less urinary calcium excretion and by biochemical evidence of greater bone formation and reduced bone resorption. However, no trial has tested the effect of increased potassium or diets rich in potassium on bone mineral density or clinical outcomes related to osteoporosis. 

Microscopy (qv) plays a key role in examining trace evidence owing to the small size of the evidence and a desire to use nondestmctive testing (qv) techniques whenever possible. Polarizing light microscopy (43,44) is a method of choice for crystalline materials. Microscopy and microchemical analysis techniques (45,46) work well on small samples, are relatively nondestmctive, and are fast. Evidence such as sod, minerals, synthetic fibers, explosive debris, foodstuff, cosmetics (qv), and the like, lend themselves to this technique as do comparison microscopy, refractive index, and density comparisons with known specimens. Other microscopic procedures involving infrared, visible, and ultraviolet spectroscopy (qv) also are used to examine many types of trace evidence. 

Bentonite has expected sihca content of 0.5 weight percent (F is 0.005). Silica density (A ) is 2.4 gm per cii cm, and bentonite (Ag) is 2.6. The calculation requires knowledge of mineral properties described by the factor (fghd ). Value of the factor can be estabhshed from fundamental data (Gy) or be derived from previous experience. In this example, data from testing a shipment of bentonite of 10 mesh top-size screen analysis determined value of the mineral factor to be 0.28. This value is scaled by the cube of diameter to ys-in screen size of the example shipment. The mineral factor is scaled from 0.28 to 52 by multiplying 0.28 with the ratio of cubed 9.4 mm (ys-in screen top-size of the shipment to be tested) and cubed 1.65 mm (equivalent to 10 mesh). 

Weanling female rats were used as the test model in these studies. They were housed individually (10 rats/diet) and offered diet and deionized water ad libitum for 5 months. Apparent calcium and phosphorus absorption and urinary Ca and P losses were measured on collections made the last five days each month. Urine volume and pH values were also recorded. Other data (growth response, serum Ca and P levels, femur mineral composition, femur strength and density, and femur histology) were obtained at the end of the 5-month feeding study. Details of this and the analytical methods used are presented elsewhere (8). All data were subjected to appropriate statistical analyses. 

Several refinements of our experiments could test these theories further. By measuring etch pit densities as well as pit dimensions on sequentially-etched crystals, nucleation rate data and pit growth data could be collected, yielding information about the rate-limiting steps and mechanisms of dissolution. In addition, since the critical concentration is extremely dependent on surface energy of the crystal-water interface (Equation 4), careful measurement of Ccrit yields a precise measurement of Y. Our data indicates an interfacial energy of 280 + 90 mjm- for Arkansas quartz at 300°C, which compares well with Parks value of 360 mJm for 25°C (10). Similar experiments on other minerals could provide essential surface energy data. 

---